Adroit Pharmaceuticals Private Limited, a active private limited company, was established on 25 April 1977 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1977PTC019620. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.90 M.
It upholds a compliant status. Employing 52 professional, Its leadership includes Ghanshyamdas Hassanand Kukreja (Director), Sanjay Kukreja Cheturam (Director), Bhupendra Abhimanyu Kukreja (Director). Past directors included Deepak Arjundas Kukreja, Anil Arjundas Kukreja. It holds ₹40.07 Cr open charges and ₹16.36 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 1003, Eternity A Wing,Raheja Reflections Thakur Village Road, Kandivali (East),, Mumbai, Maharashtra, 400101.
U24239MH1977PTC019620
019620
25 April 1977
₹1.00 M
₹0.90 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Adroit Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ghanshyamdas Hassanand Kukreja | Director | 19 Oct 1981 | Current |
| Sanjay Kukreja Cheturam | Director | 10 Mar 1997 | Current |
| Bhupendra Abhimanyu Kukreja | Director | 10 Mar 1997 | Current |
| Cheturam Hassanand Kukreja | Director | 19 Oct 1981 | Current |
| Abhimanyu Hassanand Kukreja | Director | 24 Apr 1979 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Apr 2019 | Past |
| Pramod Abcsdd | Director | 15 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adroit Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.58% increase. The company also saw a slight decrease in profitability, with a 6.18% decrease in profit. The company's net worth Soared by an impressive increase of 17.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Adroit Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹400,700,000.00
₹163,602,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2022 | Others | ₹15.00 Cr | Open |
| 16 Sep 2021 | Axis Bank Limited | ₹22.49 Cr | Open |
| 20 Jun 2020 | Others | ₹3.00 M | Open |
| 31 Oct 2019 | Others | ₹2.28 Cr | Open |
| 09 Jun 2020 | Others | ₹9.43 M | Satisfied |
Explore comprehensive loan charge details -
Adroit Pharmaceuticals has a workforce of 52 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Adroit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adroit Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Axis Bank Limited of Rs. 224.90 M registered on 16 Sep 2021 with Charge ID 100488736 was modified on 30 May 2025. was documented.
Adroit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Adroit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge with Others amounted to Rs. 150.00 M with Charge ID 100558429 was registered on 23 Mar 2022. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 224.90 M with Charge ID 100488736 was registered on 16 Sep 2021. was documented.
A charge registered on 09 Jun 2020 via Charge ID 100339573 with Others was fully satisfied on 14 Sep 2021. was recorded as a recent event.
The CIN of Adroit Pharmaceuticals Private Limited is U24239MH1977PTC019620.
Adroit Pharmaceuticals Private Limited is headquartered at Flat No. 1003, Eternity A Wing,Raheja Reflections Thakur Village Road, Kandivali (East),, Mumbai, Maharashtra, 400101.
Adroit Pharmaceuticals Private Limited was incorporated on 25 April 1977.
The current directors of Adroit Pharmaceuticals Private Limited are
The primary industry of Adroit Pharmaceuticals Private Limited is Manufacturing.
Adroit Pharmaceuticals Private Limited is unlisted.
The authorized capital of Adroit Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.90 M.
The compliance status of Adroit Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX